\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationSevilla, Spain
ProgrammesThere is 1 attachment connected to this article.
Attachments are only accessible for people with an account on the NCP Flanders website.
The SESAR institutional partnership and the University of Seville (Faculty of Engineering) are organising SESAR's annual Innovation Days (SIDs) in Seville, 27-30 November 2023. Speakers include academics and researchers, European Commission officials, large enterprise representatives, ...
It predominantly focusses on sharing progress and disseminating exploratory research results in the air traffic management (ATM) field, in combination with showcasing industrial research and demonstrations.
In addition to various technical paper sessions, the plenary sessions will focus on:
You can find more information on the official website. The draft agenda is added to this message, but is obviously subject to change.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
